Cardiovascular disease post coronary artery bypass graft. Myocardial infarction specified as acute or with a stated duration of 4 weeks (28 days) or less from onset
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria: sinus rhythm,left ventricular ejection fraction =50% and 4- 16 week after coronary artery bypass graft surgery; Exclusion criteria: coexisting valvular and/or peripheral vascular diseases, frequent atrial or ventricular premature beats, conduction defects, pericarditis, peripheral neuropathy, orthopedic or neurological limitations, cessation of drug use during the study
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Resting heart rate. Timepoint: Befor and after 6 week. Method of measurement: Polar beat heart rate.;Ejection fraction. Timepoint: Befor and after 6 week intervention. Method of measurement: 2 dimentional echocardiography.;Maximal heart rate. Timepoint: Befor and after 6 week intervention. Method of measurement: Polar beat heart rate.;Cardiad out put. Timepoint: Befor and after 6 week intervention. Method of measurement: 2 dimentional echocardiography.;Rate product pressure. Timepoint: Befor and after 6 week of intervention. Method of measurement: 2 dimentional echocardiography.;End-systolic diameter. Timepoint: Befor and after 6 week of intervention. Method of measurement: 2 dimentional echocardiography.;End-diastolic diameter. Timepoint: Befor and after 6 week of intervention. Method of measurement: 2 dimentional echocardiography.;Stroke volume. Timepoint: Befor and after 6 week of intervention. Method of measurement: 2 dimentional echocardiography.;Heart rate variabality. Timepoint: Befor and after 6 week of intervention. Method of measurement: Cardiac hollter monitoring.;Quality of life. Timepoint: Befor and after 6 week of intervention. Method of measurement: The World Health Organization Quality of Life Questionnaire.;Plasma glucose level. Timepoint: Befor and after 6 week of intervention. Method of measurement: Enzymatic.;Serum triglycerides. Timepoint: Befor and after 6 week intervention. Method of measurement: Photometry.;Serum cholestrol. Timepoint: Befor and after 6 week of intervention. Method of measurement: Photometry.;Serum LDL. Timepoint: Befor and after 6 week of intervention. Method of measurement: Photometry.;Serum HDL. Timepoint: Befor and after 6 week of intervention. Method of measurement: Photometry.;Blood pressure. Timepoint: Befor and after 6 week of intervention. Method of measurement: Barometer. | — |
Countries
Iran (Islamic Republic of)
Contacts
Baqiyatallah University of Medical Sciences